These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26763372)
1. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation. Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372 [No Abstract] [Full Text] [Related]
2. A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aalpha Arg439-->Cys. Hanss M; Vergnes C; Rugeri L; Ffrench P; DE Mazancourt P J Thromb Haemost; 2008 Aug; 6(8):1422-4. PubMed ID: 18485090 [No Abstract] [Full Text] [Related]
3. Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype. Abdelghani E; Dawson J; Zajo K; Hallam M; Dunn A; Kumar R Pediatr Blood Cancer; 2021 Mar; 68(3):e28713. PubMed ID: 33058516 [No Abstract] [Full Text] [Related]
4. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227 [No Abstract] [Full Text] [Related]
5. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200+1G>T]). Angles-Cano E; Mathonnet F; Dreyfus M; Claeyssens S; de Mazancourt P Blood Coagul Fibrinolysis; 2007 Jan; 18(1):73-5. PubMed ID: 17179831 [TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Miesbach W; Galanakis D; Scharrer I Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502 [TBL] [Abstract][Full Text] [Related]
7. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation. Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512 [TBL] [Abstract][Full Text] [Related]
8. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation. Brennan SO; Mosesson MW; Lowen R; Frantz C Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657 [No Abstract] [Full Text] [Related]
9. Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy. Stikarová J; Blatný J; Kotlín R; Suttnar J; Zapletal O; Pimková K; Májek P; Hrachovinová I; Dyr JE Thromb Res; 2013 Oct; 132(4):490-2. PubMed ID: 24050829 [No Abstract] [Full Text] [Related]
10. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317 [TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis. Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446 [TBL] [Abstract][Full Text] [Related]
12. Exon skipping and aberrant signal peptide cleavage produce novel fibrinogen with an Aα chain lacking the first 42 residues. Brennan SO; Laurie AD; McRae S Thromb Haemost; 2016 Aug; 116(3):581-5. PubMed ID: 27277572 [No Abstract] [Full Text] [Related]
13. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain]. Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582 [TBL] [Abstract][Full Text] [Related]
14. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)). Jayo A; Arnold E; González-Manchón C; Green D; Lord ST Thromb Haemost; 2009 Apr; 101(4):770-2. PubMed ID: 19350124 [No Abstract] [Full Text] [Related]
15. [A case of dysfibrinogenemia complicated by hemorrhage and thrombosis]. Ouvry PA; Vergoz D; Guenneguez H Phlebologie; 1985; 38(3):417-20. PubMed ID: 4059342 [TBL] [Abstract][Full Text] [Related]
16. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation. Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242 [TBL] [Abstract][Full Text] [Related]
17. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations. Brennan SO; Fellowes AP; Faed JM; George PM Blood; 2000 Mar; 95(5):1709-13. PubMed ID: 10688828 [TBL] [Abstract][Full Text] [Related]
18. A nonsense mutation in FGA g.3807C-->T (p.R159X) causes afibrinogenaemia in the homozygous form. Marchi Cappelletti R; Tersek Y; Ruiz-Sáez A; Meyer M Acta Haematol; 2009; 121(4):216-7. PubMed ID: 19468208 [No Abstract] [Full Text] [Related]
19. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Davis RL; Brennan SO Thromb Haemost; 2007 Nov; 98(5):1136-8. PubMed ID: 18000621 [No Abstract] [Full Text] [Related] [Next] [New Search]